NCT02238145View on ClinicalTrials.gov

Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease

CompletedOBSERVATIONAL
Enrollment

660

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

November 30, 1999

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Atrovent® Inhaletten

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02238145 - Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease | Biotech Hunter | Biotech Hunter